University of Texas Health Science Center at Tyler
Tyler, Texas 75799
1 studies enrolling now · 22 studies all time
What they study most
Alpha-1 Antitrypsin Deficiency, Alpha1-antitrypsin Deficiency, Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IV Breast Cancer AJCC v8, Atrial Fibrillation, Atrial Flutter, Breast Adenocarcinoma, Bronchiectasis, Carcinoma, Non-Small-Cell Lung, Chronic Obstructive Pulmonary Disease, Cystic Fibrosis, Diabetes
Studies at this site
- The AIRTIVITY™ Study: A Study to Find Out Whether BI 1291583 Helps People With Bronchiectasis — Recruiting now
- A Study Comparing Tarlatamab, Durvalumab, Carboplatin, and Etoposide Versus Durvalumab, Carboplatin, and Etoposide in First-line Extensive Stage Small-Cell Lung Cancer (ES-SCLC) — Recruiting now
- Clairleafᵀᴹ: A Study to Test Long-term Treatment With BI 1291583 in People With Bronchiectasis Who Took Part in a Previous Study With This Medicine — Running, not enrolling
- Exemestane With or Without Entinostat in Treating Patients With Recurrent Hormone Receptor-Positive Breast Cancer That is Locally Advanced or Metastatic — Running, not enrolling
- A Study to Test Whether Different Doses of BI 1291583 Help People With Bronchiectasis — Completed
- Erlotinib Hydrochloride and Cabozantinib-s-Malate Alone or in Combination as Second or Third Line Therapy in Treating Patients With Stage IV Non-small Cell Lung Cancer — Running, not enrolling
- Study to Evaluate the Safety, Phage Kinetics, and Efficacy of Inhaled AP-PA02 in Subjects With Non-Cystic Fibrosis Bronchiectasis and Chronic Pulmonary Pseudomonas Aeruginosa Infection — Completed
- Centralized Lung Cancer EARly Detection Among Smokers (CLEAR Study) — Running, not enrolling
- Safe Babies: Parenting Action Plan ( PAP ) — Completed
- Acthar Gel in Participants With Pulmonary Sarcoidosis — Completed
- GLASSIA Safety, Immunogenicity, and Bronchoalveolar Lavage Study — Completed
- GLORIA-AF Registry Program - Second and Third Phases — Completed
- Care Optimization Through Patient and Hospital Engagement Clinical Trial for Heart Failure — Completed
- Safety and Efficacy of a Lysophosphatidic Acid Receptor Antagonist in Idiopathic Pulmonary Fibrosis — Completed
- Avelumab in Non-Small Cell Lung Cancer (JAVELIN Lung 200) — Completed
- Study Assessing the Safety, Tolerability, Pharmacokinetics, Food Effect, and Drug-Drug Interactions of PTI-801 in Healthy Volunteers, and Safety, Tolerability, and Pharmacokinetics of PTI-801 in Subjects With Cystic Fibrosis — Completed
- Continuous Glucose Monitoring in Critically Ill — Stopped early
- Efficacy and Safety Study of AeroVanc for the Treatment of Persistent MRSA Lung Infection in Cystic Fibrosis Patients — Completed
- Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation — Completed
- Safety and Effectiveness of AZLI (an Inhaled Antibiotic) in Adults With Non-Cystic Fibrosis Bronchiectasis — Completed
- Safety and Effectiveness of AZLI (an Inhaled Antibiotic) in Adults With Non-Cystic Fibrosis Bronchiectasis — Completed
- Prevalence of Alpha-1 Antitrypsin Deficiency in Chronic Obstructive Pulmonary Disease (COPD) — Completed